BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27365088)

  • 1. Shed proteoglycans in tumor stroma.
    Piperigkou Z; Mohr B; Karamanos N; Götte M
    Cell Tissue Res; 2016 Sep; 365(3):643-55. PubMed ID: 27365088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase.
    Fitzgerald ML; Wang Z; Park PW; Murphy G; Bernfield M
    J Cell Biol; 2000 Feb; 148(4):811-24. PubMed ID: 10684261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecans as modulators and potential pharmacological targets in cancer progression.
    Barbouri D; Afratis N; Gialeli C; Vynios DH; Theocharis AD; Karamanos NK
    Front Oncol; 2014; 4():4. PubMed ID: 24551591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecans in heart fibrosis.
    Lunde IG; Herum KM; Carlson CC; Christensen G
    Cell Tissue Res; 2016 Sep; 365(3):539-52. PubMed ID: 27411689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.
    Theocharis AD; Skandalis SS; Tzanakakis GN; Karamanos NK
    FEBS J; 2010 Oct; 277(19):3904-23. PubMed ID: 20840587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of proteoglycans in the reactive stroma on tumor growth and progression.
    Coulson-Thomas YM; Gesteira TF; Norton AL; Kao WW; Nader HB; Coulson-Thomas VJ
    Histol Histopathol; 2015 Jan; 30(1):33-41. PubMed ID: 24931397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shedding of cell membrane-bound proteoglycans.
    Nam EJ; Park PW
    Methods Mol Biol; 2012; 836():291-305. PubMed ID: 22252642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteoglycans in health and disease: the multiple roles of syndecan shedding.
    Manon-Jensen T; Itoh Y; Couchman JR
    FEBS J; 2010 Oct; 277(19):3876-89. PubMed ID: 20840585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
    Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
    J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive and accelerated shedding of murine syndecan-1 is mediated by cleavage of its core protein at a specific juxtamembrane site.
    Wang Z; Götte M; Bernfield M; Reizes O
    Biochemistry; 2005 Sep; 44(37):12355-61. PubMed ID: 16156648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shedding; towards a new paradigm of syndecan function in cancer.
    Choi S; Lee H; Choi JR; Oh ES
    BMB Rep; 2010 May; 43(5):305-10. PubMed ID: 20510012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyromonas gingivalis lipopolysaccharide induces shedding of syndecan-1 expressed by gingival epithelial cells.
    Andrian E; Grenier D; Rouabhia M
    J Cell Physiol; 2005 Jul; 204(1):178-83. PubMed ID: 15648090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proteoglycans in the liver].
    Kovalszky I; Dudás J; Gallai M; Hollósi P; Tátrai P; Tátrai E; Schaff Z
    Magy Onkol; 2004; 48(3):207-13. PubMed ID: 15520870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1 in B lymphoid malignancies.
    Sanderson RD; Børset M
    Ann Hematol; 2002 Mar; 81(3):125-35. PubMed ID: 11904737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.
    Brule S; Charnaux N; Sutton A; Ledoux D; Chaigneau T; Saffar L; Gattegno L
    Glycobiology; 2006 Jun; 16(6):488-501. PubMed ID: 16513763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteoglycans remodeling in cancer: Underlying molecular mechanisms.
    Theocharis AD; Karamanos NK
    Matrix Biol; 2019 Jan; 75-76():220-259. PubMed ID: 29128506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of proteoglycan core proteins in human bone marrow stroma.
    Schofield KP; Gallagher JT; David G
    Biochem J; 1999 Nov; 343 Pt 3(Pt 3):663-8. PubMed ID: 10527946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.
    Theocharis AD; Gialeli C; Bouris P; Giannopoulou E; Skandalis SS; Aletras AJ; Iozzo RV; Karamanos NK
    FEBS J; 2014 Nov; 281(22):5023-42. PubMed ID: 25333340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.
    Iozzo RV; Sanderson RD
    J Cell Mol Med; 2011 May; 15(5):1013-31. PubMed ID: 21155971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
    Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
    Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.